INCR

Intercure Ltd

3.97

Oct 30 • 3:59 PM ET -0.15 (-3.64%)

3.97

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic Israel Nano NASD

Peers: IMCC ACB TLRY CRON OGI CGC HITI TRLV CPIX SNDL

Scroll to Statements

Index	-
Market Cap	47.04M
Enterprise Value	89.13M
Income	-10.76M
Sales	78.55M
Book/sh	11.38
Cash/sh	1.29
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	285
IPO	Jan 28, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	0.60
P/B	0.35
P/C	3.08
P/FCF	-
EV/EBITDA	-
EV/Sales	1.13
Quick Ratio	0.95
Current Ratio	1.48
Debt/Eq	0.46
LT Debt/Eq	0.20
Option/Short	Yes / Yes

EPS (ttm)	-1.00
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- 14.69%
Sales past 3/5Y	-12.19% 32.88%
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-71.12%
Sales Q/Q	-1.48%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	39.17%
Insider Trans	0.00%
Inst Own	2.69%
Inst Trans	-1.93%
ROA	-
ROE	-
ROIC	-7.21%
Gross Margin	8.70%
Oper. Margin	-27.06%
Profit Margin	-13.69%
SMA20	-16.00%
SMA50	-21.90%
SMA200	-14.05%
Trades

Shs Outstand	9.11M
Shs Float	7.21M
Short Float	0.06%
Short Ratio	0.20
Short Interest	0.00M
52W High	7.55 -47.41%
52W Low	3.40 16.76%
Volatility	4.71% 4.28%
ATR (14)	0.24
RSI (14)	29.18
Beta	1.47
Rel Volume	0.66
Avg Volume	22.11K
Volume	14,680

Perf Week	-12.36%
Perf Month	-26.07%
Perf Quarter	-16.68%
Perf Half Y	-10.55%
Perf YTD	-12.75%
Perf Year	-43.29%
Perf 3Y	-24.38%
Perf 5Y	-88.29%
Perf 10Y	-
Recom	1.00
Target Price	7.17
Prev Close	4.12
Price	3.97
Change %	-3.64%

Consensus

Strong Buy

Avg. Price Target

$7.17

Implied Upside

+80.6%

Analysts1incl. previous ratings

Rating Distribution1 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
May 18, 2022	Upgrade	CCanaccord Genuity	Speculative Buy → Buy	$13	+227.5%

Sep-08-26 04:12PM	InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Aug-24-26 07:00AM	InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages (GlobeNewswire) +28.71%
Aug-19-26 09:00AM	InterCure Ltd. Announces 1-for-5 Reverse Share Split (GlobeNewswire)
Jun-22-26 08:50AM	InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds (GlobeNewswire) +17.37%
Jun-15-26 09:25AM	InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition (GlobeNewswire) +9.27%
06:05PM	Loading…
Apr-30-26 06:05PM	InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow (GlobeNewswire) +5.45%
Mar-03-26 04:46PM	InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement (GlobeNewswire)
Feb-19-26 07:00AM	InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million (GlobeNewswire) -5.78%
Nov-03-25 08:30AM	InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation (GlobeNewswire)
Oct-08-25 09:40AM	InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow (GlobeNewswire)
Sep-19-25 10:06AM	InterCure Enters Premium US Cannabis Market With ISHI Deal (Benzinga)
08:48AM	InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands (GlobeNewswire)
May-01-25 04:00PM	InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 (PR Newswire)
Feb-12-25 06:35PM	InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak (PR Newswire)
Dec-20-24 08:32AM	InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility (PR Newswire) +11.19%
06:37PM	Loading…
Sep-01-24 06:37PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Aug-29-24 06:03PM	InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million (GlobeNewswire)
Aug-28-24 08:54AM	InterCure Announces Expansion of its Strategic partnership with Cookies to Germany (Business Wire) +6.10%
May-22-24 06:45AM	InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference (Business Wire) -6.06%
May-01-24 08:27AM	InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million (Business Wire)
Apr-01-24 09:09AM	InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million (Business Wire)
Mar-22-24 11:58AM	InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint (Business Wire) +11.89%
Feb-13-24 04:46PM	InterCure Provides an Update Regarding Nir Oz Facility (GlobeNewswire) -7.26%
Jan-31-24 09:27AM	InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain (GlobeNewswire)
Oct-31-23 04:39PM	InterCure Wins Cannolam Arbitration Proceeding (GlobeNewswire)
Oct-17-23 05:04PM	InterCure Provides an Update Regarding the Security Situation in Israel (GlobeNewswire) -6.13%
Aug-31-23 07:45PM	InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY (GlobeNewswire) +6.62%
Jul-10-23 05:00PM	InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE (GlobeNewswire) +7.64%
Jun-09-23 05:18PM	InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger (GlobeNewswire) -5.91%
May-15-23 05:59PM	InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference (GlobeNewswire) -6.98%
05:45PM	Loading…
05:45PM	InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY (GlobeNewswire)
08:30AM	InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business (GlobeNewswire)
Apr-25-23 07:19PM	InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary (GlobeNewswire) +5.53%
Apr-24-23 05:59PM	InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel (GlobeNewswire)
Apr-20-23 08:30AM	InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries (GlobeNewswire) +6.82%
Apr-03-23 03:27PM	InterCure Reschedules 2022 Full Year Results Conference Call (GlobeNewswire) +25.74%
Mar-31-23 08:00PM	InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results (GlobeNewswire)
Feb-14-23 08:30AM	InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger (GlobeNewswire)
Feb-01-23 08:30AM	InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better) (GlobeNewswire)
Dec-19-22 08:30AM	InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske" (GlobeNewswire)
Dec-08-22 09:30AM	InterCure to Participate in Cowen 5th Annual Cannabis Conference (GlobeNewswire)
Dec-05-22 04:30PM	InterCure Announces the Withdrawal of a Class Action Lawsuit against it (GlobeNewswire)
Nov-23-22 04:30PM	Update regarding Better Transaction (GlobeNewswire)
Nov-17-22 08:17AM	Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies (GlobeNewswire) -5.58%
Nov-15-22 11:18AM	CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth (GlobeNewswire)
09:03AM	InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth (GlobeNewswire)
Nov-11-22 08:32AM	InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million 63% Growth YoY (GlobeNewswire)
Sep-16-22 04:30PM	Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders (GlobeNewswire) +6.47%
Aug-15-22 09:15AM	InterCure Reports Record Breaking Second Quarter Financial Results (GlobeNewswire)
Aug-11-22 10:30AM	InterCure to Release its Q2 2022 Results and Hold a Conference Call (GlobeNewswire)
Jul-21-22 09:00AM	InterCure Reports Record Preliminary 2022 Second Quarter Revenue More Than Double YoY and 9% QoQ Growth (GlobeNewswire) +6.67%
Jul-18-22 08:00AM	Clever Leaves Announces First Export to Israeli Partner InterCure (GlobeNewswire)
Jun-21-22 08:40AM	InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria (GlobeNewswire) +8.22%
Jun-02-22 08:30AM	InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel (GlobeNewswire)
May-19-22 11:36AM	InterCure (Class A) (INCR) Q1 2022 Earnings Call Transcript (Motley Fool)
May-16-22 05:50PM	InterCure Begins 2022 with Record Breaking First Quarter Financial Results (GlobeNewswire)
01:30AM	InterCure to Release its Q1 2022 Results and Hold a Conference Call (GlobeNewswire)
May-09-22 11:20AM	InterCure to Participate in Upcoming Investor Conferences in May 2022 (GlobeNewswire)
May-03-22 11:28AM	InterCure to Participate in A.G.P.s Spring Consumer Cannabis Conference (GlobeNewswire)
Apr-11-22 08:05PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Apr-06-22 12:39AM	InterCure Reports Record Breaking Q4 and 2021 Results Exceeded Preliminary Results (GlobeNewswire)
Apr-05-22 08:47AM	InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022 (GlobeNewswire)
Apr-04-22 09:33AM	CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1) (GlobeNewswire)
08:29AM	InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1) (GlobeNewswire)
Apr-03-22 03:35AM	InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022 (GlobeNewswire)
Mar-30-22 09:00AM	InterCure to Hold 2021 Q4 & Year-End Webcast (GlobeNewswire)
Mar-28-22 07:00AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Mar-22-22 08:52AM	InterCure and Clever Leaves Announce International Strategic Partnership (GlobeNewswire)
08:30AM	InterCure and Clever Leaves Announce an International Strategic Partnership (GlobeNewswire)
Mar-15-22 11:34AM	InterCure to Participate in ROTH Capitals 34th Annual Conference (GlobeNewswire)
Mar-01-22 01:00AM	InterCure Announces Partnership with Altman Health (GlobeNewswire)
Feb-21-22 11:42AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Feb-16-22 01:00AM	InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer Better (GlobeNewswire)
Feb-14-22 08:43PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -15.24%
Feb-08-22 01:00AM	InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth (GlobeNewswire)
Feb-07-22 08:38PM	Ibex Investors LLC Buys Rada Electronics Industries, American Well Corp, Innovid Corp, Sells ... (GuruFocus.com)
Dec-02-21 08:15AM	InterCure Announces European Expansion with International Cannabis Brand Cookies (GlobeNewswire)
08:03AM	International Cannabis Brand Cookies and InterCure Announce European Expansion (Business Wire)
Nov-29-21 08:30AM	InterCure to Participate in Cowens 4th Annual Cannabis Conference (GlobeNewswire)
Nov-15-21 07:00PM	InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth (GlobeNewswire) -5.79%
06:50PM	InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month (GlobeNewswire)
Nov-11-21 08:00AM	InterCure Schedules Third Quarter 2021 Financial Results Conference Call (GlobeNewswire) +7.81%
Oct-29-21 04:34PM	The Week In Cannabis: Stocks Underperform, Policy Moves, Earnings, Pitbull, Lil Kim, Justin Bieber, Martha Stewart And More (Benzinga)
Oct-25-21 01:30AM	InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth (GlobeNewswire) +7.59%
Oct-13-21 12:15PM	InterCure to Present in Benzinga Cannabis Capital Conference (GlobeNewswire)
Oct-12-21 02:00AM	InterCure CEO Alex Rabinovitch Purchases Over 420,000 Shares of Company Stock in The Open Market (GlobeNewswire)
Sep-15-21 08:59AM	Cathie Wood Is Selling These 10 Stocks (Insider Monkey)
Sep-13-21 08:43AM	Cannabis Industry Investor Presentations Now Available for On-Demand Viewing (PR Newswire)
Sep-08-21 09:57AM	InterCure to Webcast Live at VirtualInvestorConferences.com September 9th (PR Newswire)
Sep-03-21 09:29AM	InterCure Re-Announces its Record-Breaking Second Quarter Financial Results With 4 Times YOY Revenue Growth - Following NASDAQ Listing (GlobeNewswire)
08:35AM	Cannabis Executives Present: Cannabis Investor Conference September 8th & 9th (PR Newswire)
Sep-02-21 09:39AM	InterCure Continuing its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition of Cannomed Pharmacy Chain (GlobeNewswire)
Sep-01-21 01:00AM	InterCure Commences Trading on NASDAQ Under the Symbol INCR (GlobeNewswire) +9.22%

Show Previous News

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.

FounderMr. Alexander Rabinovich

Chief Financial OfficerMr. Amos Cohen

Chief Executive Officer of RetailMs. Einat Zehavi

Chief Technology OfficerMr. Omer Layani

Head of MarketingMr. Yarin Lidor

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INCR

Intercure Ltd

Upgrade your Finviz experience